Inventor
Angibaud Patrick René
FR21 patents
⚠️ This page may combine multiple inventors who share the name “Angibaud Patrick René”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
11 patentsUS9447098B2Sep 20, 2016
Pteridines as FGFR inhibitors
ASTEX THERAPEUTICS LTD35 citations94
US9464071B2Oct 11, 2016
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD24 citations93
US9303030B2Apr 5, 2016
Compounds
ASTEX THERAPEUTICS LTD26 citations93
US9850228B2Dec 26, 2017
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD17 citations91
US10039759B2Aug 7, 2018
Quinolines as FGFR kinase modulators
ASTEX THERAPEUTICS LTD11 citations84
US9493426B2Nov 15, 2016
Quinazolinone derivatives useful as FGFR kinase modulators
ASTEX THERAPEUTICS LTD20 citations84
US10519137B2Dec 31, 2019
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD6 citations83
US9856236B2Jan 2, 2018
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD16 citations83
US9737544B2Aug 22, 2017
Compounds
ASTEX THERAPEUTICS LTD15 citations83
US9757364B2Sep 12, 2017
Naphthyridine derivative compounds
ASTEX THERAPEUTICS LTD15 citations79
US10272087B2Apr 30, 2019
Pteridines as FGFR inhibitors
ASTEX THERAPEUTICS LTD5 citations73
JANSSEN PHARMACEUTICA NV
5 patentsUS11396517B1Jul 26, 2022
Exo-aza spiro inhibitors of menin-MLL interaction
JANSSEN PHARMACEUTICA NV6 citations71
US10745409B2Aug 18, 2020
Azepane inhibitors of menin-MLL interaction
JANSSEN PHARMACEUTICA NV1 citations60
US8916554B2Dec 23, 2014
Amino-derivatives as novel inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV0 citations52
US9078896B2Jul 14, 2015
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV0 citations48
US11130751B2Sep 28, 2021
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors
JANSSEN PHARMACEUTICA NV0 citations47